Skip to content
healthcare.dev

Gnaphalium Polycephalum

NDC 37662-0932, Gnaphalium Polycephalum, pellet, from Hahnemann Laboratories, INC..

Product NDC
37662-0932
Status
Listed
Labeler
Hahnemann Laboratories, INC.
Dosage form
PELLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/37662-0932 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PSEUDOGNAPHALIUM OBTUSIFOLIUM200 [hp_C]/1
Package NDCNDC-11Package
37662-0932-137662093201200 PELLET in 1 VIAL, GLASS (37662-0932-1)
37662-0932-237662093202500 PELLET in 1 VIAL, GLASS (37662-0932-2)
37662-0932-3376620932033000 PELLET in 1 BOTTLE, GLASS (37662-0932-3)
37662-0932-43766209320410000 PELLET in 1 BOTTLE, GLASS (37662-0932-4)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 37662-0932 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/37662-0932 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 37662-0932. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.